426 related articles for article (PubMed ID: 23520265)
1. Pharmacodynamic effects of a D-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic pain.
Hopkins SC; Zhao FY; Bowen CA; Fang X; Wei H; Heffernan ML; Spear KL; Spanswick DC; Varney MA; Large TH
J Pharmacol Exp Ther; 2013 Jun; 345(3):502-11. PubMed ID: 23520265
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal clonidine suppresses phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit in spinal dorsal horn neurons of rats with neuropathic pain.
Roh DH; Kim HW; Yoon SY; Seo HS; Kwon YB; Han HJ; Beitz AJ; Lee JH
Anesth Analg; 2008 Aug; 107(2):693-700. PubMed ID: 18633054
[TBL] [Abstract][Full Text] [Related]
4. Spinal D-amino acid oxidase contributes to neuropathic pain in rats.
Zhao WJ; Gao ZY; Wei H; Nie HZ; Zhao Q; Zhou XJ; Wang YX
J Pharmacol Exp Ther; 2010 Jan; 332(1):248-54. PubMed ID: 19828879
[TBL] [Abstract][Full Text] [Related]
5. Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury.
Suzuki R; Dickenson AH
Exp Neurol; 2006 Mar; 198(1):72-80. PubMed ID: 16336968
[TBL] [Abstract][Full Text] [Related]
6. A novel rat forelimb model of neuropathic pain produced by partial injury of the median and ulnar nerves.
Yi H; Kim MA; Back SK; Eun JS; Na HS
Eur J Pain; 2011 May; 15(5):459-66. PubMed ID: 20965754
[TBL] [Abstract][Full Text] [Related]
7. Effects of koumine, an alkaloid of Gelsemium elegans Benth., on inflammatory and neuropathic pain models and possible mechanism with allopregnanolone.
Xu Y; Qiu HQ; Liu H; Liu M; Huang ZY; Yang J; Su YP; Yu CX
Pharmacol Biochem Behav; 2012 May; 101(3):504-14. PubMed ID: 22366214
[TBL] [Abstract][Full Text] [Related]
8. Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms.
Christoph T; Reissmüller E; Schiene K; Englberger W; Chizh BA
Brain Res; 2005 Jun; 1048(1-2):218-27. PubMed ID: 15922311
[TBL] [Abstract][Full Text] [Related]
9. Transient allodynia pain models in mice for early assessment of analgesic activity.
Gil DW; Cheevers CV; Donello JE
Br J Pharmacol; 2008 Feb; 153(4):769-74. PubMed ID: 17700719
[TBL] [Abstract][Full Text] [Related]
10. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
11. Biphasic effects of chronic intrathecal gabapentin administration on the expression of protein kinase C gamma in the spinal cord of neuropathic pain rats.
Yeh CY; Chung SC; Tseng FL; Tsai YC; Liu YC
Acta Anaesthesiol Taiwan; 2011 Dec; 49(4):144-8. PubMed ID: 22221687
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
13. Triptolide prevents and attenuates neuropathic pain via inhibiting central immune response.
Wang W; Mei XP; Chen L; Tang J; Li JL; Wu SX; Xu LX; Li YQ
Pain Physician; 2012; 15(6):E995-1006. PubMed ID: 23159984
[TBL] [Abstract][Full Text] [Related]
14. Pre-emptive intrathecal quinidine alleviates spinal nerve ligation-induced peripheral neuropathic pain.
Cheng KI; Wang HC; Lai CS; Tsai HP; Kwan AL; Ho ST; Wang JJ; Chang LL
J Pharm Pharmacol; 2011 Aug; 63(8):1063-9. PubMed ID: 21718290
[TBL] [Abstract][Full Text] [Related]
15. Chronic spinal nerve ligation induces changes in response characteristics of nociceptive spinal dorsal horn neurons and in their descending regulation originating in the periaqueductal gray in the rat.
Pertovaara A; Kontinen VK; Kalso EA
Exp Neurol; 1997 Oct; 147(2):428-36. PubMed ID: 9344567
[TBL] [Abstract][Full Text] [Related]
16. The antihyperalgesic effects of intrathecal bupropion, a dopamine and noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.
Hoshino H; Obata H; Nakajima K; Mieda R; Saito S
Anesth Analg; 2015 Feb; 120(2):460-6. PubMed ID: 25427287
[TBL] [Abstract][Full Text] [Related]
17. The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury.
Suzuki R; Stanfa LC; Kowaluk EA; Williams M; Jarvis MF; Dickenson AH
Br J Pharmacol; 2001 Apr; 132(7):1615-23. PubMed ID: 11264257
[TBL] [Abstract][Full Text] [Related]
18. Long-term synaptic plasticity in the spinal dorsal horn and its modulation by electroacupuncture in rats with neuropathic pain.
Xing GG; Liu FY; Qu XX; Han JS; Wan Y
Exp Neurol; 2007 Dec; 208(2):323-32. PubMed ID: 17936754
[TBL] [Abstract][Full Text] [Related]
19. Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models.
Piesla MJ; Leventhal L; Strassle BW; Harrison JE; Cummons TA; Lu P; Whiteside GT
Brain Res; 2009 Oct; 1295():89-98. PubMed ID: 19651113
[TBL] [Abstract][Full Text] [Related]
20. The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function.
Munro G; Storm A; Hansen MK; Dyhr H; Marcher L; Erichsen HK; Sheykhzade M
Pharmacol Biochem Behav; 2012 May; 101(3):465-78. PubMed ID: 22366217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]